![AVR](https://iperfusion.org/wp-content/uploads/2024/02/IMG_0451-300x171.jpeg)
The Northern New England Rapid Deployment Valve Experience: Survival and Procedural Outcomes From 2015 to 2021
This study examines the outcomes of rapid deployment aortic valve replacement (rdAVR) compared to stented aortic valve replacement (sAVR) in patients undergoing isolated aortic valve replacement or combined procedures with coronary artery bypass grafting from 2015 to 2021. Utilizing data from the Northern New England Cardiovascular Database, the research found that rdAVR offers significant advantages in terms of shorter cross-clamp and cardiopulmonary bypass times without compromising immediate postoperative gradients or long-term survival. However, rdAVR is associated with higher pacemaker rates, especially in larger valve sizes. The study concludes that rdAVR is a viable and safe alternative to sAVR, necessitating further long-term follow-up.